Logo-jcvtr
J Cardiovasc Thorac Res. 2025;17(4): 215-217. doi: 10.34172/jcvtr.025.33793
PMID: 41836208        PMCID: PMC12980093

Editorial

The cardiovascular safety of GLP-1 receptor agonists: From glucose control to cardiometabolic protection

Samad Ghaffari 1 ORCID, Seyedeh-Tarlan Mirzohreh 1 ORCID, Neda Roshanravan 1 * ORCID, Faezeh Tarighat 1 * ORCID

Cited by CrossRef:


1- Parekh R, Inban P, Thai A, Agrawal A, Kudaiarov D, Tariq H. GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review. Disease-a-Month. 2026;:102150 [Crossref]